Mitant 12.5mg Sunitinib Price USA | Ernest Oncology Indian Exporter

Mitant 12.5mg Capsule: Precision Targeted Therapy for Oncology

Are you looking for a trusted Mitant 12.5 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced oncology medications. We cater to major international markets, including the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, providing high-quality pharmaceutical solutions with professional B2B support.

Product Overview: What is Mitant 12.5 mg?

Mitant 12.5 mg is an oral targeted therapy medication containing Sunitinib Malate. It belongs to the class of Tyrosine Kinase Inhibitors (TKIs) and is widely utilized in modern oncology to treat specific types of tumors that are resistant to traditional chemotherapy.

Primary Therapeutic Indications:

Mitant 12.5 mg is clinically indicated for:

• Renal Cell Carcinoma (RCC): Advanced kidney cancer.

• Gastrointestinal Stromal Tumors (GIST): Rare cancers of the digestive tract, especially after other treatments (like imatinib) have failed.

• Pancreatic Neuroendocrine Tumors (pNET): Progressive, well-differentiated tumors of the pancreas.

• Medullary Thyroid Cancer: Used as a targeted intervention for specific thyroid malignancies.

Mechanism of Action: How Mitant Works:

Mitant works by inhibiting multiple receptor tyrosine kinases (RTKs) that are overactive in cancer cells. These receptors are responsible for signaling the cell to grow and divide.

1. Inhibition of Tumor Growth: It blocks receptors like PDGFR and KIT, which are essential for cancer cell survival.

2. Anti-Angiogenesis: It targets VEGFR (Vascular Endothelial Growth Factor Receptors), preventing the formation of new blood vessels that the tumor needs to receive oxygen and nutrients.

3. Metastasis Prevention: By disrupting these cellular pathways, Mitant helps slow down or stop the spread of cancer to other parts of the body.

Dosage and Administration Guidelines:

• Cycle for RCC/GIST: Often prescribed as 50 mg (multiple capsules) daily for 4 weeks, followed by a 2-week break.

• Continuous Dosing for pNET: Typically 37.5 mg daily without a rest period.

• Method: Take the capsule whole with water. It can be taken with or without food, but consistency in timing is key.

• Warning: Avoid grapefruit and Seville oranges, as they can significantly alter the drug's metabolism in your system.

Common Side Effects & Monitoring:

While effective, patients may experience:

• Fatigue, nausea, or diarrhea.

• Hand-Foot Syndrome: Redness or pain on the palms and soles.

• High blood pressure (hypertension).

• Changes in taste or skin discoloration.

• Monitoring: Regular checks of thyroid function, liver enzymes (LFTs), and blood pressure are essential during therapy.

Why Source Mitant 12.5 mg from Ernest Oncology?

• Quality Assurance: We supply authentic medications manufactured by Hetero Healthcare, a world leader in oncology.

• Bulk Availability: Consistent stock for clinical and hospital requirements.

• Global Export Expertise: Seamless shipping and customs handling for the USA, UK, UAE, Australia, and South Africa

• Competitive B2B Pricing: Specialized rates for international distributors and healthcare providers.